2201-35-6 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

2201-35-6 Usage

Uses

Methoxydine contains pharamcological activity and found to be one of novel analogs of ketamine and phencyclidine as NMDA receptor antagonists.

Check Digit Verification of cas no

The CAS Registry Mumber 2201-35-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,0 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2201-35:
(6*2)+(5*2)+(4*0)+(3*1)+(2*3)+(1*5)=36
36 % 10 = 6
So 2201-35-6 is a valid CAS Registry Number.

2201-35-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	1-[1-(4-methoxyphenyl)cyclohexyl]piperidine

1.2 Other means of identification

Product number	-
Other names	-

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2201-35-6 SDS

2201-35-6Upstream product

2201-35-6Downstream Products

80770-70-3 4-(1-Piperidin-1-yl-cyclohexyl)-phenol; hydrobromide

2201-35-6Relevant articles and documents

Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists

Zarantonello, Paola,Bettini, Ezio,Paio, Alfredo,Simoncelli, Chiara,Terreni, Silvia,Cardullo, Francesco

, p. 2059 - 2063 (2011/04/24)

The identification of structurally novel analogues of ketamine and phencyclidine (PCP), as NMDA receptor antagonists, with low to moderate potency at GluN2A and GluN2B receptors is discussed. In particular, some examples, such as compounds 6 and 10, shows decreased calculated lipophilicity, when compared to PCP, while retaining moderate activity. Moreover, the germinal aryl amino substituted lactam ring, as exemplified in compounds 7-10 and 11-13, constitutes a novel scaffold with potential application in the design of biologically active compounds.

CAS

2201-35-6